Tenaya Therapeutics, Inc. (TNYA) - Quarterly Income Statement

Home
TNYA
Financials

1.35 (USD) • At close September 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	0	0	17.664	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	2.084	0	0	0	2.123	2.155	2.987	2.977	2.971	2.884	2.853	2.802	1.76	1.298	1.112	1.055	0.998	0.689	0	0	0	0
Gross Profit Numbers are in millions	-2.084	0	0	0	-2.123	-2.155	14.677	-2.977	-2.971	-2.884	-2.853	-2.802	-1.76	-1.298	-1.112	-1.055	-0.998	-0.689	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0.831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	17.37	21.076	18.688	20.35	22.649	25.055	22.865	23.091	26.477	25.605	25.748	23.758	20.876	24.155	20.953	12.944	10.906	9.59	8.364	8.48	6.958	7.297
General & Administrative Expenses Numbers are in millions	6.712	6.462	5.964	6.361	8.174	8.707	8.581	7.829	8.627	8.118	8.802	7.54	7.743	6.999	5.211	5.356	4.331	3.515	1.958	1.972	1.914	1.969
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-2.123	-2.155	-2.987	-2.977	-2.971	-2.884	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.628	6.462	5.964	6.361	6.051	6.552	5.594	4.852	5.656	5.234	8.802	7.54	7.743	6.999	5.211	5.356	4.331	3.515	1.958	1.972	1.914	1.969
Other Expenses Numbers are in millions	0	0	0	0	-0.001	0.082	0.041	0.001	-0.002	0.013	-0.003	0.006	0	-0.001	-0.054	0.015	0.018	-0.002	-0.001	0	0	0
Operating Expenses Numbers are in millions	21.998	27.538	24.652	26.711	28.7	31.607	28.459	27.943	32.133	30.839	34.55	31.298	28.619	31.154	26.164	18.3	15.237	13.105	10.322	10.452	8.872	9.266
Operating Income Numbers are in millions	-24.082	-27.538	-24.652	-26.711	-30.823	-33.762	-31.446	-30.92	-35.104	-33.723	-34.55	-31.298	-28.619	-31.154	-26.164	-18.3	-15.237	-13.105	-10.322	-10.452	-8.872	-9.266
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	-1.78	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.799	0.674	0.816	1.077	1.392	1.534	1.511	1.777	1.835	1.986	1.034	0.602	0.222	0.098	0.013	0.038	0.027	0.007	0.004	0.157	0.141	0.215
Income Before Tax Numbers are in millions	-23.283	-26.864	-23.836	-25.634	-29.431	-32.228	-29.935	-29.143	-33.269	-31.737	-33.516	-30.696	-28.397	-31.056	-26.151	-18.262	-15.21	-13.098	-10.318	-10.295	-8.731	-9.051
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	-1.695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0.92	-0.602	-0.222	-0.098	0	-0.038	-0.036	-0.007	-0.009	0	0	0
Net Income Numbers are in millions	-23.283	-26.864	-23.836	-25.634	-29.431	-32.228	-29.935	-29.143	-33.269	-31.737	-34.436	-30.094	-28.175	-30.958	-26.151	-18.262	-15.21	-13.098	-10.318	-10.295	-8.731	-9.051
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	-1.695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.143	-0.24	-0.28	-0.3	-0.34	-0.4	-0.44	-0.39	-0.45	-0.43	-0.62	-0.73	-0.68	-0.75	-0.63	-0.68	-0.41	-0.48	-0.38	-0.38	-0.32	-0.33
EPS Diluted Numbers are in millions	-0.143	-0.24	-0.28	-0.3	-0.34	-0.4	-0.44	-0.39	-0.45	-0.43	-0.62	-0.73	-0.68	-0.75	-0.63	-0.68	-0.41	-0.48	-0.38	-0.38	-0.32	-0.33
EBITDA Numbers are in millions	-21.199	-24.877	-22.563	-24.61	-28.7	-31.607	-29.265	-28.739	-32.909	-31.593	-32.433	-29.211	-27.322	-30.188	-25.039	-17.554	-14.502	-12.416	-9.664	-9.821	-8.262	-8.682
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	-1.657	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Tenaya Therapeutics, Inc.

NASDAQ:TNYA Add to watchlist

NASDAQ:TNYA